▶
Key Milestones in Evolution of Biopharmaceutical & Vaccine Manufacturing (Lionel Gerentes, Sanofi)
Dr Lionel Gerentes (Head of Viral & Bacterial Scientific Excellence , MSAT Vaccine, Sanofi) introduces key milestones over the last 80 years in the evolution of biopharmaceutical and vaccine manufacturing. Presented as part of the session: Can Vaccines Turn the Tide on Neglected & Tropical Diseases?
With the following presentations:
Control measures for neglected tropical diseases: vaccine updates
Dr Vivek Chavda (Department of Pharmaceutics and Pharmaceutical Technology, LM College of Pharmacy, Ahmedabad, India) and Prof Vasso Apostolopoulos (Head of the Healthy Lifespan and Chronic Diseases Program, School of Health and Biomedical Sciences, RMIT University, Australia)
Identifying WHO global priority endemic pathogens for vaccine research and development (R&D): an objective of the Immunization Agenda 2030
Dr Bernadette Abela-Ridder (Team Leader, Neglected Zoonotic Diseases, World Health Organization)
Key Milestones in Evolution of Biopharmaceutical & Vaccine Manufacturing
Dr Lionel Gerentes (Head of Viral & Bacterial Scientific Excellence , MSAT Vaccine, Sanofi)
Pre-clinical studies of Schistosoma mansoni vaccines
Dr Emma Houlder (Leiden University Center for Infectious Diseases, The Netherlands)
Recorded on Dec 3 2025 as part of the ISNTD D3V scientific meeting
https://www.isntd.org/isntd-d3